The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update
Abstract
You have accessJournal of UrologyAdult urology1 Jun 2007Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Updateis accompanied byQuantifying the Impact of Prostate Volumes, Number of Biopsy Cores and 5α-Reductase Inhibitor Therapy on the Probability of Prostate Cancer Detection Using Mathematical Modeling Ian Thompson, James Brantley Thrasher, Gunnar Aus, Arthur L. Burnett, Edith D. Canby-Hagino, Michael S. Cookson, Anthony V. D’Amico, Roger R. Dmochowski, David T. Eton, Jeffrey D. Forman, S. Larry Goldenberg, Javier Hernandez, Celestia S. Higano, Stephen R. Kraus, Judd W. Moul, Catherine M. Tangen, and Prostate Cancer Clinical Guideline Update Panel Ian ThompsonIan Thompson Financial interest and/or other relationship with Mission Pharmacal, AstraZeneca and National Institutes of Health. More articles by this author , James Brantley ThrasherJames Brantley Thrasher Financial interest and/or other relationship with Medidiom and Abbott. More articles by this author , Gunnar AusGunnar Aus Financial interest and/or other relationship with Bok Medical. More articles by this author , Arthur L. BurnettArthur L. Burnett Financial interest and/or other relationship with Pfizer, Lilly ICOS and Guilford/MOI Pharma. More articles by this author , Edith D. Canby-HaginoEdith D. Canby-Hagino More articles by this author , Michael S. CooksonMichael S. Cookson Financial interest and/or other relationship with Sanofi-Aventis, GlaxoSmithKline, Envisioneering Medical Technologies, Aeterna Zentaris Solvay, Photocure, National Institutes of Health and GTX. More articles by this author , Anthony V. D’AmicoAnthony V. D’Amico More articles by this author , Roger R. DmochowskiRoger R. Dmochowski Financial interest and/or other relationship with Indevus, Watson Pharmaceuticals and Bard. More articles by this author , David T. EtonDavid T. Eton More articles by this author , Jeffrey D. FormanJeffrey D. Forman More articles by this author , S. Larry GoldenbergS. Larry Goldenberg More articles by this author , Javier HernandezJavier Hernandez More articles by this author , Celestia S. HiganoCelestia S. Higano More articles by this author , Stephen R. KrausStephen R. Kraus Financial interest and/or other relationship with National Institute for Diabetes and Digestive and Kidney Diseases, Pfizer, Atellas, Novartis and Ortho McNeil. More articles by this author , Judd W. MoulJudd W. Moul Financial interest and/or other relationship with AstraZeneca, Pfizer, Sanofi-Aventis and GlaxoSmithKline. More articles by this author , Catherine M. TangenCatherine M. Tangen More articles by this author , and Prostate Cancer Clinical Guideline Update Panel More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2007.03.003AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail Introduction In December 1995, the AUA published the Report on the Management of Clinically Localized Prostate Cancer.1 The document was the culmination of six years of work by 17 clinicians and scientists and required the evaluation of 12,501 scientific publications with the detailed extraction of information from 165 papers that met the rigorous criteria of the panel of experts (Appendix 1 on-line). The Panel noted that a lack of evidence precluded specific recommendations for optimal treatment of an individual patient, which patients should be offered all treatment options, and that patient preferences should guide decision making. Since 1995, approximately 2,600,000 men2 in the United States have been diagnosed with prostate cancer, and nearly 375,000 men3,4 have lost their lives to this disease. In addition, the National Cancer Institute4 has spent $2.1 billion on prostate cancer research and as of November 2005, approximately 28,111 scientific papers concerning prostate cancer have been published in peer-reviewed medical journals (OVID Search, December 31, 1995 to October 23, 2005; key word: prostatic neoplasms). At the same time, mortality rates from prostate cancer have been declining: 34,475 men died in 1995 compared with an estimated 30,350 in 2005.4 Several pivotal RCTs related to prostate cancer treatment have been completed, including a chemoprevention study,5 along with studies demonstrating prolongation of life in men with hormone-refractory metastatic disease6,7 and improved outcomes in men with nonmetastatic disease.8–35 With the use of new and combined treatments, the frequency and variety of complications have differed from those previously reported. Advances have been made in prostate cancer imaging, biopsy methodology, in understanding causative factors and disease, in treatment-related QOL and in predicting the behavior of individual tumors using risk strata. Despite these advances, no consensus has emerged regarding the optimal treatment for the most common patient with prostate cancer: the man with clinically localized stage T1 to T2 disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rosen, R. C., Riley, A., Wagner, G., Osterloh, I. H., Kirkpatrick, J., & Mishra, A. (1997) · Urology · doi:10.1016/s0090-4295(97)00238-0 · Cited by 5,849
Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
Tannock, I. F., de Wit, R., Berry, W. R., Horti, J., Pluzanska, A., Chi, K. N., Oudard, S., Théodore, C., James, N. D., Turesson, I., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040720 · Cited by 5,735
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., Smigal, C., & Thun, M. J. (2006) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.56.2.106 · Cited by 5,314
D'Amico, A. V. (1998) · JAMA · doi:10.1001/jama.280.11.969 · Cited by 4,523
Self-citationPetrylak, D. P., Tangen, C. M., Hussain, M. H. A., Lara, P. N., Jones, J. A., Taplin, M. E., Burch, P. A., Berry, D., Moinpour, C., Kohli, M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041318 · Cited by 3,665
Self-citationThe Influence of Finasteride on the Development of Prostate Cancer
Thompson, I. M., Goodman, P. J., Tangen, C. M., Lucia, M. S., Miller, G. J., Ford, L. G., Lieber, M. M., Cespedes, R. D., Atkins, J. N., Lippman, S. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030660 · Cited by 2,518
Self-citationSathianathen, N. (2021) · 50 Studies Every Urologist Should Know · doi:10.1093/med/9780190655341.003.0002 · Cited by 2,080
Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer
Bill-Axelson, A., Holmberg, L., Ruutu, M., Garmo, H., Stark, J. R., Busch, C., Nordling, S., Häggman, M., Andersson, S.-O., Bratell, S., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1011967 · Cited by 1,900
Bolla, M., Collette, L., Blank, L., Warde, P., Dubois, J. B., Mirimanoff, R.-O., Storme, G., Bernier, J., Kuten, A., Sternberg, C., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09408-4 · Cited by 1,686 · cited 2×
“0002) among prostate cancer patients with clinical stage T1 to T2 with World Health Organization grade 3 tumors, or cT3 to T4N0-1M0 any grade tumors compared to radiotherapy alone.(11) Similar results have been found by Radiation Therapy Oncology Groups 8531 (Table 4)(24) and 9202 (Table 4).”
BackgroundResultDiabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer
Keating, N. L., O'Malley, A. J., & Smith, M. R. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.2497 · Cited by 1,455
Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial
Pollack, A., Zagars, G. K., Starkschall, G., Antolak, J. A., Lee, J. J., Huang, E., von Eschenbach, A. C., Kuban, D. A., & Rosen, I. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)02829-8 · Cited by 1,333
Zietman, A. L., DeSilvio, M. L., Slater, J. D., Rossi, C. J., Miller, D. W., Adams, J. A., & Shipley, W. U. (2005) · JAMA · doi:10.1001/jama.294.10.1233 · Cited by 1,224
Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer
Bill-Axelson, A., Holmberg, L., Ruutu, M., Häggman, M., Andersson, S.-O., Bratell, S., Spångberg, A., Busch, C., Nordling, S., Garmo, H., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043739 · Cited by 1,111
Quality-of-life outcomes in men treated for localized prostate cancer
Litwin, M. S., Hays, R. D., Fink, A., Ganz, P. A., Leake, B., Leach, G. E., & Brook, R. H. (1995) · JAMA · doi:10.1001/jama.1995.03520260051032 · Cited by 1,020
Stanford, J. L., Feng, Z., Hamilton, A. S., Gilliland, F. D., Stephenson, R. A., Eley, J. W., Albertsen, P. C., Harlan, L. C., & Potosky, A. L. (2000) · JAMA · doi:10.1001/jama.283.3.354 · Cited by 956
LITWIN, M. S., McNAUGHTON-COLLINS, M., FOWLER, F. J., NICKEL, J. C., CALHOUN, E. A., PONTARI, M. A., ALEXANDER, R. B., FARRAR, J. T., & O'LEARY, M. P. (1999) · Journal of Urology · doi:10.1016/s0022-5347(05)68562-x · Cited by 947
Cookson, M. S., Aus, G., Burnett, A. L., Canby-Hagino, E. D., D’Amico, A. V., Dmochowski, R. R., Eton, D. T., Forman, J. D., Goldenberg, S. L., Hernandez, J., et al. (2007) · Journal of Urology · doi:10.1016/j.juro.2006.10.097 · Cited by 844
Self-citationPilepich, M. V., Winter, K., John, M. J., Mesic, J. B., Sause, W., Rubin, P., Lawton, C., Machtay, M., & Grignon, D. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(01)01579-6 · Cited by 772
D'Amico, A. V., Manola, J., Loffredo, M., Renshaw, A. A., DellaCroce, A., & Kantoff, P. W. (2004) · JAMA · doi:10.1001/jama.292.7.821 · Cited by 767
Self-citationPreoperative PSA Velocity and the Risk of Death from Prostate Cancer after Radical Prostatectomy
D'Amico, A. V., Chen, M.-H., Roehl, K. A., & Catalona, W. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032975 · Cited by 740
Self-citationPOTENCY, CONTINENCE AND COMPLICATION RATES IN 1,870 CONSECUTIVE RADICAL RETROPUBIC PROSTATECTOMIES
CATALONA, W. J., CARVALHAL, G. F., MAGER, D. E., & SMITH, D. S. (1999) · Journal of Urology · doi:10.1016/s0022-5347(05)68578-3 · Cited by 716
Natural History of Early, Localized Prostate Cancer
Johansson, J.-E. (2004) · JAMA · doi:10.1001/jama.291.22.2713 · Cited by 703
Hanks, G. E., Pajak, T. F., Porter, A., Grignon, D., Brereton, H., Venkatesan, V., Horwitz, E. M., Lawton, C., Rosenthal, S. A., Sandler, H. M., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.11.023 · Cited by 689
Potosky, A. L., Davis, W. W., Hoffman, R. M., Stanford, J. L., Stephenson, R. A., Penson, D. F., & Harlan, L. C. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh259 · Cited by 680
The Problem of Quality of Life in Medicine
Leplège, A. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550010061041 · Cited by 640
Roach, M., DeSilvio, M., Lawton, C., Uhl, V., Machtay, M., Seider, M. J., Rotman, M., Jones, C., Asbell, S. O., Valicenti, R. K., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.004 · Cited by 637
Sakr, W. A., Grignon, D. J., Crissman, J. D., Heilbrun, L. K., Cassin, B. J., Pontes, J. J., & Haas, G. P. (1994) · PubMed · Cited by 575
Sexual Function following Radical Prostatectomy: Influence of Preservation of Neurovascular Bundles
Quinlan, D. M., Epstein, J. I., Carter, B. S., & Walsh, P. C. (1991) · Journal of Urology · doi:10.1016/s0022-5347(17)38512-9 · Cited by 510
FACTORS PREDICTING RECOVERY OF ERECTIONS AFTER RADICAL PROSTATECTOMY
RABBANI, F., STAPLETON, A. M. F., KATTAN, M. W., WHEELER, T. M., & SCARDINO, P. T. (2000) · Journal of Urology · doi:10.1016/s0022-5347(05)66921-2 · Cited by 487
D’Amico, A. V., Moul, J., Carroll, P. R., Sun, L., Lubeck, D., & Chen, M.-H. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.01.075 · Cited by 455
Self-citationLITWIN, M. S., LUBECK, D. P., HENNING, J. M., & CARROLL, P. R. (1998) · Journal of Urology · doi:10.1016/s0022-5347(01)63222-1 · Cited by 401
Prostate Cancer and the Will Rogers Phenomenon
Albertsen, P. C., Hanley, J. A., Barrows, G. H., Penson, D. F., Kowalczyk, P. D. H., Sanders, M. M., & Fine, J. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji248 · Cited by 382
United States life tables, 2003.
Arias, E. (2006) · PubMed · Cited by 375
Lawton, C. A., Winter, K., Murray, K., Machtay, M., Mesic, J. B., Hanks, G. E., Coughlin, C. T., & Pilepich, M. V. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)01516-9 · Cited by 374
Return of Erections and Urinary Continence Following Nerve Sparing Radical Retropubic Prostatectomy
Catalona, W. J., & Basler, J. W. (1993) · Journal of Urology · doi:10.1016/s0022-5347(17)35645-8 · Cited by 357
Active Surveillance for Prostate Cancer: For Whom?
Klotz, L. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.3134 · Cited by 353
Randomized Trial Comparing Two Fractionation Schedules for Patients With Localized Prostate Cancer
Lukka, H., Hayter, C., Julian, J. A., Warde, P., Morris, W. J., Gospodarowicz, M., Levine, M., Sathya, J., Choo, R., Prichard, H., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.153 · Cited by 349
Prostate cancer and health‐related quality of life: a review of the literature
Eton, D. T., & Lepore, S. J. (2002) · Psycho-Oncology · doi:10.1002/pon.572 · Cited by 346
Self-citationSOLOWAY, M. S., PAREEK, K., SHARIFI, R., WAJSMAN, Z., McLEOD, D., WOOD, D. P., PURAS-BAEZ, A., & THE LUPRON DEPOT NEOADJUVANT PROSTATE CANCER STUDY GROUP† (2002) · Journal of Urology · doi:10.1016/s0022-5347(05)65393-1 · Cited by 341
Quality of Life Assessment: Key Issues in the 1990s
(1993) · Springer eBooks · doi:10.1007/978-94-011-2988-6 · Cited by 331
Quality of life in adult survivors of lung, colon and prostate cancer
Schag, C. A. C., Ganz, P. A., Wing, D. S., Sim, M. S., & Lee, J. J. (1994) · Quality of Life Research · doi:10.1007/bf00435256 · Cited by 329
GLEAVE, M. E., GOLDENBERG, S. L., CHIN, J. L., WARNER, J., SAAD, F., KLOTZ, L. H., JEWETT, M., KASSABIAN, V., CHETNER, M., DUPONT, C., et al. (2001) · Journal of Urology · doi:10.1016/s0022-5347(05)65971-x · Cited by 326
Self-citationD’Amico, A. V., Renshaw, A. A., Sussman, B., & Chen, M.-H. (2005) · JAMA · doi:10.1001/jama.294.4.440 · Cited by 323
Self-citationWallner, K., Roy, J., & Harrison, L. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.2.449 · Cited by 317
Middleton, R. G., Thompson, I. M., Austenfeld, M. S., Cooner, W. H., Correa, R. J., Gibbons, R. P., Miller, H. C., Oesterling, J. E., Resnick, M. I., & Smalley, S. R. (1995) · PubMed · Cited by 261
Self-citationZelefsky, M. J., Hollister, T., Raben, A., Matthews, S., & Wallner, K. E. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)00550-2 · Cited by 258
[Measuring quality of life in palliative care].
Ferreira, P. L., Barros, A. P., & Brito, A. B. (2008) · PubMed · Cited by 254
Patient-Reported Impotence and Incontinence After Nerve-Sparing Radical Prostatectomy
Talcott, J. A., Rieker, P., Propert, K. J., Clark, J. A., Kantoff, P. W., Wishnow, K. I., Loughlin, K. R., & Richie, J. P. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.15.1117 · Cited by 249
Efficace, F., Bottomley, A., Osoba, D., Gotay, C., Flechtner, H., D’haese, S., & Zurlo, A. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.12.121 · Cited by 246
Schulman, C. C., Debruyne, F. M. J., Forster, G., Selvaggi, F. P., Zlotta, A. R., & Witjes, W. P. J. (2000) · European Urology · doi:10.1159/000020366 · Cited by 246
See, W. A., Wirth, M. P., McLeod, D. G., Iversen, P., Klimberg, I., Gleason, D., Chodak, G., Montie, J., Tyrrell, C., Wallace, D. M. A., et al. (2002) · Journal of Urology · doi:10.1016/s0022-5347(05)64652-6 · Cited by 230
Delayed Versus Immediate Surgical Intervention and Prostate Cancer Outcome
Warlick, C., Trock, B. J., Landis, P., Epstein, J. I., & Carter, H. B. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj072 · Cited by 219
Middleton, R. G., Thompson, I. M., Austenfeld, M. S., Cooner, W. H., Correa, R. J., Gibbons, R. P., Miller, H. C., Oesterling, J. E., Resnick, M. I., Smalley, S. R., et al. (1995) · Journal of Urology · doi:10.1016/s0022-5347(01)66718-1 · Cited by 214
Self-citationWIRTH, M. P., SEE, W. A., McLEOD, D. G., IVERSEN, P., MORRIS, T., CARROLL, K., & ON BEHALF OF THE CASODEX EARLY PROSTATE CANCER TRIALISTS' GROUP (2004) · Journal of Urology · doi:10.1097/01.ju.0000140159.94703.80 · Cited by 209
Assessing health-related quality of life for clinical decision-making
Patrick, D. L., & Erickson, P. (1993) · Quality of Life Assessment: Key Issues in the 1990s · doi:10.1007/978-94-011-2988-6_2 · Cited by 203
KLOTZ, L. H., GOLDENBERG, S. L., JEWETT, M. A. S., FRADET, Y., NAM, R., BARKIN, J., CHIN, J., CHATTERJEE, S., & THE CANADIAN URO-ONCOLOGY GROUP (2003) · Journal of Urology · doi:10.1097/01.ju.0000081404.98273.fd · Cited by 199
Self-citationMeasuring quality of life in palliative care.
Cella, D. F. (1995) · PubMed · Cited by 196
Beard, C. J., Propert, K. J., Rieker, P. P., Clark, J. A., Kaplan, I., Kantoff, P. W., & Talcott, J. A. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.1.223 · Cited by 191
Health Related Quality of Life in Men With Prostate Cancer
PENSON, D. F., LITWIN, M. S., & AARONSON, N. K. (2003) · Journal of Urology · doi:10.1097/01.ju.0000061964.49961.55 · Cited by 176
Lubeck, D. P., Litwin, M. S., Henning, J. M., Stoddard, M. L., Flanders, S. C., & Carroll, P. R. (1999) · Urology · doi:10.1016/s0090-4295(98)00408-7 · Cited by 169
TALCOTT, J. A., CLARK, J. A., STARK, P. C., & MITCHELL, S. P. (2001) · Journal of Urology · doi:10.1016/s0022-5347(05)65970-8 · Cited by 169
McCammon, K. A., Kolm, P., Main, B., & Schellhammer, P. F. (1999) · Urology · doi:10.1016/s0090-4295(99)00163-6 · Cited by 167
Hoffman, R. M., Hunt, W. C., Gilliland, F. D., Stephenson, R. A., & Potosky, A. L. (2003) · Cancer · doi:10.1002/cncr.11233 · Cited by 162
Assessment of quality of life in clinical trials
Schumacher, M., Olschewski, M., & Schulgen, G. (1991) · Statistics in Medicine · doi:10.1002/sim.4780101207 · Cited by 159
Contemporary patterns of androgen deprivation therapy use for newly diagnosed prostate cancer
Meng, M. V., Grossfeld, G. D., Sadetsky, N., Mehta, S. S., Lubeck, D. P., & Carroll, P. R. (2002) · Urology · doi:10.1016/s0090-4295(02)01560-1 · Cited by 156
Goldenberg, S. L., Klotz, L. H., Srigley, J. R., et al. (1996) · PubMed · Cited by 150
Self-citationRECOVERY OF HEALTH RELATED QUALITY OF LIFE IN THE YEAR AFTER RADICAL PROSTATECTOMY: EARLY EXPERIENCE
Litwin, M. S., McGuigan, K. A., Shpall, A. I., & Dhanani, N. (1999) · The Journal of Urology · doi:10.1097/00005392-199902000-00043 · Cited by 146
Zeléfsky, M. J., & Whitmore, J. (1997) · The Journal of Urology · doi:10.1097/00005392-199707000-00005 · Cited by 144
Salomon, L., Anastasiadis, A. G., Katz, R., TAILLE, A. D. L., Saint, F., Vordos, D., Cicco, A., Hoznek, A., Chopin, D. K., & Abbou, C.-C. C. (2002) · European Urology · doi:10.1016/s0302-2838(02)00360-3 · Cited by 135
Quality of life assessment: Key issues in the 1990s
Aaronson, N. K. (1993) · Quality of Life Research · doi:10.1007/bf00434802 · Cited by 135
THE DEVELOPMENT OF ERECTILE DYSFUNCTION IN MEN TREATED FOR PROSTATE CANCER
Siegel, T. S., Moul, J. W., Spevak, M., Alvord, W. G., & Costabile, R. A. (2001) · The Journal of Urology · doi:10.1097/00005392-200102000-00019 · Cited by 133
Self-citationLaverdière, J., Nabid, A., de Bedoya, L. D., Ébacher, A., Fortin, A., Wang, C. S., & HAREL, F. (2004) · The Journal of Urology · doi:10.1097/01.ju.0000112979.97941.7f · Cited by 130
Current Status of HIFU and Cryotherapy in Prostate Cancer – A Review
Aus, G. (2006) · European Urology · doi:10.1016/j.eururo.2006.07.011 · Cited by 128
Self-citationBeckendorf, V., Guerif, S. G., Prisé, É. L., Cosset, J. M., Floch, O. L., Chauvet, B., Salem, N., Chapet, O., Bourdin, S., Bachaud, J. M., et al. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.05.033 · Cited by 127
Goldenberg, S. L., Klotz, L. H., Srigley, J. R., et al. (1996) · The Journal of Urology · doi:10.1016/s0022-5347(01)65645-3 · Cited by 125
Self-citationActive surveillance with selective delayed intervention for favorable risk prostate cancer
Klotz, L. H. (2006) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2005.07.002 · Cited by 119
Comparison of biochemical failure definitions for permanent prostate brachytherapy
Kuban, D. A., Levy, L. B., Potters, L., BEYER, D. C., Blasko, J. C., Moran, B. J., Ciezki, J. P., Zietman, A. L., Zeléfsky, M. J., Pisansky, T. M., et al. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.03.027 · Cited by 118
Crook, J., Ludgate, C. M., Malone, S. C., Perry, G., Eapen, L. J., Bowen, J., Robertson, S. J., & Lockwood, G. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.04.075 · Cited by 117
Crook, J. M., Ludgate, C. M., Malone, S. C., Lim, J. T. W., Perry, G., Eapen, L., Bowen, J., Robertson, S., & Lockwood, G. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.02.022 · Cited by 112
Introduction: Resilience of cancer survivors across the lifespan
Rowland, J. H., & Baker, F. (2005) · Cancer · doi:10.1002/cncr.21487 · Cited by 106
Iversen, P., Johansson, J., Lodding, P., Lukkarinen, O. A., Lundmo, P. I., Klarskov, P., Tammela, T. L. J., Taşdemir, İ., Morris, T., Carroll, K., et al. (2004) · The Journal of Urology · doi:10.1097/01.ju.0000139719.99825.54 · Cited by 98
Joly, F., Brune, D., Couette, J. E., Lesaunier, F., Héron, J., Pény, J., & Henry-Amar, M. (1998) · Annals of Oncology · doi:10.1023/a:1008276632623 · Cited by 98
Neoadjuvant hormonal therapy: The Canadian experience
Labrie, F., Cusan, L., Gomez, J., et al. (1997) · Urology · doi:10.1016/s0090-4295(97)00170-2 · Cited by 92
Fair, W. R., Cookson, M. S., Stroumbakis, N., et al. (1997) · Urology · doi:10.1016/s0090-4295(97)00169-6 · Cited by 88
Self-citationWalsh, P. C., Marschke, P., Ricker, D. D., & Burnett, A. L. “. (2000) · Urology · doi:10.1016/s0090-4295(99)00363-5 · Cited by 85
Self-citationDisease-specific survival following the brachytherapy management of prostate cancer
Stock, R. G., Cesaretti, J. A., & Stone, N. N. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.09.005 · Cited by 78
小川, 和. (2005) · Mebio oncology · Cited by 72
Neuromuscular fatigue in prostate cancer patients undergoing radiation therapy
Monga, U., Jaweed, M. M., Kerrigan, A. J., Lawhon, L., Johnson, J., Vallbona, C., & Monga, T. N. (1997) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/s0003-9993(97)90058-7 · Cited by 67
Comparison of prostate cancer patients with and without pain
Heim, H. M., & Oei, T. P. S. (1993) · Pain · doi:10.1016/0304-3959(93)90075-z · Cited by 66
QUALITY OF LIFE IN PATIENTS WITH PROSTATIC CANCER: RESULTS FROM A SWEDISH POPULATION STUDY
Borghede, G., Karlsson, J., & Sullivan, M. (1997) · The Journal of Urology · doi:10.1016/s0022-5347(01)64247-2 · Cited by 65
Prezioso, D., Lotti, T., Polito, M., & Montironi, R. (2004) · Urologia Internationalis · doi:10.1159/000077113 · Cited by 64
Lee, W. R., McQuellon, R. P., Harris‐Henderson, K., Case, L. D., & McCullough, D. L. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(99)00355-7 · Cited by 61
Standards for Clinical Trials in Male Sexual Dysfunction: Erectile Dysfunction and Rapid Ejaculation
Hirsch, M., Donatucci, C. F., Glina, S., D, D. K. M. M., Montorsi, F., & Wyllie, M. G. (2004) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2004.10113.x · Cited by 52
Bradley, E. B., Bissonette, E. A., & Theodorescu, D. (2004) · BJU International · doi:10.1111/j.1464-410x.2004.05094.x · Cited by 46
Potency Preservation After Three-Dimensional Conformal Radiotherapy for Prostate Cancer
Wilder, R. B., Chou, R. H., Ryu, J. K., Stern, R. L., Wong, M. S., Ji, M. H., Roach, M., & White, R. D. (2000) · American Journal of Clinical Oncology · doi:10.1097/00000421-200008000-00002 · Cited by 36
Complications from treatment for prostate carcinoma among men in the Detroit area
Schwartz, K., Bunner, S. H., Bearer, R., & Severson, R. K. (2002) · Cancer · doi:10.1002/cncr.10650 · Cited by 31
Reddy, S. M., Ruby, J., Wallace, M., & Forman, J. D. (1997) · Radiation Oncology Investigations · doi:10.1002/(sici)1520-6823(1997)5:5<252::aid-roi6>3.0.co;2-x · Cited by 24
Self-citationPatient-reported impotence and incontinence after nerve-sparing radical prostatectomy.
Pc, W. (1998) · PubMed · Cited by 16
Endocrine therapy with or without radical prostatectomy for T1b‐T3N0M0 prostate cancer
Homma, Y., Akaza, H., Okada, K., Yokoyama, M., Usami, M., Hirao, Y., Tsushima, T., Sakamoto, A., Ohashi, Y., Aso, Y., et al. (2004) · International Journal of Urology · doi:10.1111/j.1442-2042.2003.00781.x · Cited by 15
Localized Prostate Cancer: Quality of Life Meets Whitmore's Legacy
Bermejo, C., Kristal, A. R., Zeliadt, S. B., Ramsey, S. D., & Thompson, I. M. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh282 · Cited by 12
Self-citation
Cited by
Radical Prostatectomy versus Observation for Localized Prostate Cancer
Wilt, T. J., Brawer, M. K., Jones, K. M., Barry, M. J., Aronson, W. J., Fox, S., Gingrich, J. R., Wei, J. T., Gilhooly, P., Grob, B. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113162 · Cited by 1,770
Time Trends and Local Variation in Primary Treatment of Localized Prostate Cancer
Cooperberg, M. R., Broering, J. M., & Carroll, P. R. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.0133 · Cited by 1,006
American Cancer Society Guideline for the Early Detection of Prostate Cancer: Update 2010
Wolf, A. M. D., Wender, R. C., Etzioni, R. B., Thompson, I. M., D'Amico, A. V., Volk, R. J., Brooks, D. D., Dash, C., Guessous, I., Andrews, K., et al. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20066 · Cited by 965
Self-citationKlein, E. A., Cooperberg, M. R., Magi-Galluzzi, C., Simko, J. P., Falzarano, S. M., Maddala, T., Chan, J. M., Li, J., Cowan, J. E., Tsiatis, A. C., et al. (2014) · European Urology · doi:10.1016/j.eururo.2014.05.004 · Cited by 659
Schnipper, L. E., Smith, T. J., Raghavan, D., Blayney, D. W., Ganz, P. A., Mulvey, T. M., & Wollins, D. S. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.8375 · Cited by 649
Metadata
- Authors
- Thompson, I., Thrasher, J. B., Aus, G., Burnett, A. L., Canby-Hagino, E. D., Cookson, M. S., D’Amico, A. V., Dmochowski, R. R., Eton, D. T., Forman, J. D., Goldenberg, S. L., Hernandez, J., Higano, C. S., Kraus, S. R., Moul, J. W., Tangen, C. M., & Panel, P. C. C. G. U.
- Venue
- Journal of Urology
- Published
- 2007-06
- Volume
- 177
- Issue
- 6
- Pages
- 2106-2131
- ISSN
- 0022-5347 (ISSN-L)
- 1527-3792
- OpenAlex
- W2156549595
- Cited by
- 1,113
- References
- 100
- FWCI
- 52.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.